Your browser doesn't support javascript.
loading
Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.
Griffin, Tagan A; Schnier, Paul D; Cleveland, Elisa M; Newberry, Robert W; Becker, Julia; Carlson, George A.
Affiliation
  • Griffin TA; Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
  • Schnier PD; Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, California, USA; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
  • Cleveland EM; Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
  • Newberry RW; Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, California, USA; Department of Pharmaceutical Chemistry, University of California, San Francisco, California, USA.
  • Becker J; Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
  • Carlson GA; Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, California, USA; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA. Electronic address: george.carlson@ucsf.edu.
J Biol Chem ; 299(3): 102888, 2023 03.
Article in En | MEDLINE | ID: mdl-36634849

Full text: 1 Database: MEDLINE Main subject: Biotin / Alpha-Synuclein / Neurons Limits: Humans Language: En Journal: J Biol Chem Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Biotin / Alpha-Synuclein / Neurons Limits: Humans Language: En Journal: J Biol Chem Year: 2023 Type: Article Affiliation country: United States